Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NettaGrowth International
Uruguay
- Ownership
- Private
- Development stage
- Other
01
Overview
NettaGrowth International, via its Uruguayan subsidiary Dormul S.A., obtained the first licence in Uruguay to produce and export medical cannabis with THC for commercialization, and planned production of THC and CBD products for Latin American markets, particularly Uruguay and Brazil.[1][2][5] Dormul applied for an extraction licence and aimed to be among the first in Uruguay approved for medical cannabis-based CBD oils for domestic use and export.[1][5]
- Therapeutic areas
- PsychiatryNeurology
- Modalities
- Small moleculePlant-derived product
- Industry
- Biotech
02
Partnerships
Institut Pasteur de Montevideo
Beyond the preview
Go deeper on NettaGrowth International.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NettaGrowth International.